Alnylam Pharmaceuticals
ALNY
#561
Rank
$36.29 B
Marketcap
$281.40
Share price
0.95%
Change (1 day)
56.66%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company